The Full Story in Plain English
What the Study Found (In Plain English)
Why This Matters to You
To establish the safety of combined division of the splenic vein compared with separate division of the splenic vein. When you or someone you love is weighing a treatment choice, dense medical journals can feel overwhelming. Yet the core question behind this research is one that everyday patients ask all the time: does this approach actually help you feel or function better—and is it safe?
How the Study Worked
To find out, researchers writing in JAMA surgery conducted a phase iii randomized trial evaluating 318 real-world participants. Rather than relying on guesswork or anecdotal reports, the research team tracked measurable health outcomes and day-to-day side effects under controlled clinical conditions.
What the Study Found in Plain English
A total of 318 patients were randomly assigned, and 2 patients were excluded as ineligible. Of the 316 remaining patients, 150 (50.3%) were male. The modified intent-to-treat population constituted 159 patients (50.3%) in the separate division group and 157 patients (49.7%) in the combined division group. Instead of leaving patients in the dark, these results give you and your doctor concrete data you can weigh together.
The Catch: What to Keep in Mind
Even strong medical studies have limits. Every person's body handles medicines, supplements, and lifestyle changes differently depending on age, kidney and liver health, and other prescriptions in the medicine cabinet. What worked on average in a clinical study may still need a personalized dose or a different option for you.
Bottom Line: Your Next Step
Bring this summary to your next doctor or pharmacist visit. Ask: "Based on my health history and current medications, does this research apply to me?" You can also click the formal study link below to inspect the original peer-reviewed paper directly.
Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers
Published in JAMA surgery (2021-05-01) • Study Design: Phase III Randomized Trial • Participants: N = 318 • Biostatistical Rigor Score: 87/100. Primary Takeaway: A total of 318 patients were randomly assigned, and 2 patients were excluded as ineligible.
Study Limitations & Caveats Before You Act
While this phase iii randomized trial scored 87/100 for research quality, clinical trials follow strict rules that may not match every patient's daily life. Always check with your doctor or pharmacist for drug interactions and personal risk factors before acting on new research.
Formal Peer-Reviewed Study Reference
“Safety of Combined Division vs Separate Division of the Splenic Vein in Patients Undergoing Distal Pancreatectomy: A Noninferiority Randomized Clinical Trial”
Published in JAMA surgery (2021-05-01) • PMID/ID: 33656542